Search results for "Natural History"

showing 10 items of 124 documents

Mediterranean diet impact on cardiovascular diseases: a narrative review

2017

Cardiovascular disease (CVD) accounts for more than 17 million deaths per year worldwide. It has been estimated that the influence of lifestyle on CVD mortality amounts to 13.7% for smoking, 13.2% for poor diet, and 12% for inactive lifestyle. These results deeply impact both the healthy status of individuals and their skills in working. The impact of CVD on productivity loss accounts for the 24% in total costs for CVD management. Mediterranean diet (MedD) can positively impact on natural history of CVD. It is characterized by a relatively high consumption of inexpensive and genuine food such as cereals, vegetables, legumes, nuts, fish, fresh fruits, and olive oil as the principal source of…

lifestyleMediterranean dietinactive lifestyleDisease030204 cardiovascular system & hematologyDiet MediterraneanSudden cardiac deathCoronary artery disease03 medical and health sciencescardiovascular diseases lifestyle Mediterranean diet preventive cardiology vascular diseasesVascular Stiffness0302 clinical medicinecardiovascular diseaseEnvironmental healthMediterranean dietmedicineHumansHealthy Lifestyle030212 general & internal medicineMediterranean diet impact on cardiovascular diseasesRandomized Controlled Trials as TopicalimentationTraditional medicinebusiness.industrycardiovascular disease (CVD)preventive cardiologyfood and beveragesvascular diseasemediterranean dietGeneral Medicinemedicine.diseaseNatural historycardiovascular diseases; lifestyle; Mediterranean diet; preventive cardiology; vascular diseases; Cardiology and Cardiovascular MedicineCardiovascular Diseasesmediterranean diet cardiovascular diseaseHeart failureArterial stiffnesscardiovascular disease (CVD); inactive lifestyle; alimentationvascular diseasesNarrative reviewbusinessCardiology and Cardiovascular Medicine
researchProduct

Dal mare al museo. Il recupero di uno scheletro di stenella striata, Stenella coeruleoalba (Meyen 1833)

2022

In 2021, the Museum of Zoology “P. Doderlein” of the University of Palermo acquired a new specimen, the complete skeleton of Stenella coeruleoalba, a striped dolphin stranded in 2018 in Marinella di Selinunte, Castelvetrano (Sicily, Southern Italy). The project herein described is the result of a collaboration among the Bio-Reconstruction Laboratory of the IAS-CNR of Capo Granitola, the IZS of Palermo, the company Naturaliter and the Museum of Zoology “P. Doderlein”. In Natural History Museums, cetaceans are an excellent tool to facilitate scientific dissemination aimed at the conservation of marine biodiversity. The work herein described is presented as an example of good practices in reco…

marine mammals cetacean strandings natural history museums zoological collections outreach biodiversitySettore BIO/05 - Zoologia
researchProduct

Role of Hemodynamic Forces in Unruptured Intracranial Aneurysms: An Overview of a Complex Scenario.

2017

Background An understanding of the natural history of unruptured intracranial aneurysms (IAs) has always played a critical role in presurgical or endovascular planning, to avoid possibly fatal events. Size, shape, morphology, and location are known risk factors for rupture of an aneurysm, but morphologic parameters alone may not be sufficient to perform proper rupture risk stratification. Methods We performed a systematic PubMed search and focused on hemodynamics forces that may influence aneurysmal initiation, growth, and rupture. Results We included 223 studies describing several hemodynamic parameters related to aneurysm natural history. In these studies, different modalities of aneurysm…

medicine.medical_specialty030218 nuclear medicine & medical imagingWall shear stress03 medical and health sciences0302 clinical medicineAneurysmComputational fluid dynamicmedicineHumansRupture riskHemodynamicIntensive care medicineCerebral aneurysmHemodynamic forcesModalitiesbusiness.industryHemodynamicsIntracranial AneurysmHemodynamics Intracranial aneurysms Cerebral aneurysm Wall shear stressCcomputational fluid dynamics.Flow patternmedicine.diseaseSurgeryCerebral AngiographyNatural historyCerebrovascular CirculationTreatment strategySurgeryNeurology (clinical)business030217 neurology & neurosurgeryWorld neurosurgery
researchProduct

Cytomegalovirus and inflammatory bowel disease: Is there a link?

2006

The objective of this report is to give an overall view of the epidemiological, clinical, diagnostic and therapeutic features of Cytomegalovirus (CMV) infection in inflammatory bowel disease (IBD). A review of published reports on this topic was carried out, with particular attention paid to the selection of patients included in studies and the diagnostic methods employed. CMV is frequently associated with IBD. In some cases, CMV infection is associated with a poor outcome but it is not clear which patients are more likely to be affected and in which stage of the disease. The use of anti-viral therapy in IBD is controversial and an empirical study with controls is needed. The natural histor…

medicine.medical_specialtyAcquired Immunodeficiency Syndromebusiness.industryGastroenterologyCongenital cytomegalovirus infectionGeneral MedicineDiseasemedicine.diseaseInflammatory Bowel DiseasesInflammatory bowel diseaseAntiviral Agentsdigestive system diseasesNatural historyImmune systemEpidemiologyImmunologyCytomegalovirus InfectionsmedicineHumansTopic HighlightStage (cooking)Viral persistencebusinessImmunosuppressive Agents
researchProduct

Characteristics of patients with mucopolysaccharidosis type II who have received a bone marrow transplant: Data from the Hunter Outcome Survey

2019

Mucopolysaccharidosis type II (MPS II Hunter syndrome) is a rare, life-limiting, X-linked lysosomal storage disease. The Hunter Outcome Survey (HOS) is a Shire-sponsored, global, observational registry initiated in 2005 that collects real-world data on the natural history of MPS II and long-term treatment with enzyme replacement therapy (ERT) with idursulfase. Patients receiving other forms of pharmacological ERT are excluded from HOS but individuals who have received a bone marrow transplant (BMT) may be enrolled. This analysis examined the characteristics of 36 male patients in HOS from Europe and North America who had received a BMT (March 2018 data). In total, 22 patients (61.1%) were E…

medicine.medical_specialtyBone marrow transplantIdursulfasebusiness.industryEndocrinology Diabetes and MetabolismHunter syndromeEnzyme replacement therapymedicine.diseaseBiochemistryNatural historyEndocrinologyGraft-versus-host diseaseRespiratory failureInternal medicineGeneticsmedicineMucopolysaccharidosis type IIbusinessMolecular Biologymedicine.drugMolecular Genetics and Metabolism
researchProduct

Natural History of Mesenteric Venous Thrombosis: A Large Multicentre Study

2008

Abstract Introduction: Mesenteric venous thrombosis (MVT) is an uncommon but potentially life-threatening disease, accounting for 5–15% of mesenteric ischemic events. Most cases of MVT are either identified at laparotomy or at autopsy, with a mortality rate of approximately 50% in old series. Advances in imaging techniques have facilitated the early diagnosis of MVT and, thus, have contributed to a decrease in mortality in the more recent series. The treatment of MVT involves anticoagulation alone or in combination with surgery. Experts suggest that MVT can safely be managed without surgery if there is no evidence of bowel infarction. However, information on the natural history of MVT and o…

medicine.medical_specialtyBowel infarctionbusiness.industryMortality ratemedicine.medical_treatmentImmunologyCell BiologyHematologymedicine.diseaseBiochemistryThrombosisSurgeryNatural historymedicine.anatomical_structureSplanchnic vein thrombosisMedian follow-upLaparotomymedicineVeinbusinessBlood
researchProduct

Management of hepatitis C virus genotype 4: recommendations of an international expert panel.

2011

HCV has been classified into no fewer than six major genotypes and a series of subtypes. Each HCV genotype is unique with respect to its nucleotide sequence, geographic distribution, and response to therapy. Genotypes 1, 2, and 3 are common throughout North America and Europe. HCV genotype 4 (HCV-4) is common in the Middle East and in Africa, where it is responsible for more than 80% of HCV infections. It has recently spread to several European countries. HCV-4 is considered a major cause of chronic hepatitis, cirrhosis, hepatocellular carcinoma, and liver transplantation in these regions. Although HCV-4 is the cause of approximately 20% of the 170 million cases of chronic hepatitis C in th…

medicine.medical_specialtyCarcinoma HepatocellularGenotypeHepatitis C virusHepacivirusHepacivirusmedicine.disease_causeAntiviral AgentsPolymorphism Single NucleotideFlaviviridaeInternal medicineGenotypeEpidemiologyRibavirinmedicineHumansClinical Trials as TopicHepatologybiologybusiness.industryInterleukinsLiver Neoplasmsvirus diseasesHepatitis CHepatitis C Chronicbiology.organism_classificationmedicine.diseaseVirologydigestive system diseasesRecombinant ProteinsLiver TransplantationNatural historyHepatocellular carcinomaInterferon Type IPractice Guidelines as TopicHCVInterferonsbusiness
researchProduct

Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies

2006

Liver transplantation significantly improves the survival and quality of life of patients with end-stage cirrhosis. However, a large proportion of cirrhotic patients still die while on the transplant list because of an insufficient number of donors and because of the lack of an accurate prediction of life expectancy. Although many prognostic models have been proposed in the last two decades to predict mortality in cirrhosis, the Child–Pugh score [1] is by far the most largely used both in clinical practice and in clinical research. Recently, the model for end stage liver disease (MELD) has replaced the Child–Pugh score in the United States for prioritizing liver donor allocation [2]. MELD i…

medicine.medical_specialtyCirrhosisHepatologybusiness.industrymedicine.medical_treatmentLiver transplantationmedicine.diseaseSurgeryNatural historyModel for End-Stage Liver DiseaseQuality of lifeAscitesmedicineLife expectancyStage (cooking)medicine.symptomIntensive care medicinebusinessJournal of Hepatology
researchProduct

A 15-Year Perspective of the Fabry Outcome Survey

2016

Abstract The Fabry Outcome Survey (FOS) is an international long-term observational registry sponsored by Shire for patients diagnosed with Fabry disease who are receiving or are candidates for therapy with agalsidase alfa (agalα). Established in 2001, FOS provides long-term data on agalα safety/efficacy and collects data on the natural history of Fabry disease, with the aim of improving clinical management. The FOS publications have helped establish prognostic and severity scores, defined the incidence of specific disease variants and implications for clinical management, described clinical manifestations in special populations, confirmed the high prevalence of cardiac morbidity, and demon…

medicine.medical_specialtyEndocrinology Diabetes and MetabolismDisease030204 cardiovascular system & hematologyoutcomesFabry Outcome Survey03 medical and health sciences0302 clinical medicineInternal medicinemedicineGenetics (clinical)lcsh:R5-920agalsidase alfaFabry diseasebusiness.industryIncidence (epidemiology)Therapeutic effectEnzyme replacement therapymedicine.diseaseFabry diseaseNatural historyPediatrics Perinatology and Child HealthPhysical therapyObservational studybusinesslcsh:Medicine (General)Agalsidase alfa030217 neurology & neurosurgeryenzyme replacement therapy
researchProduct

Clinical implications of mucosal healing in the management of patients with inflammatory bowel disease

2013

AbstractThe natural history of Crohn's Disease and ulcerative colitis is characterized by repeated episodes of inflammation and ulceration of the bowel. This results in complications implying a worse quality of life and significant healthcare costs, due to hospitalization, surgery and an escalation of therapy.The main goal of the therapy in inflammatory bowel disease is to achieve and maintain disease remission, with an improved health-related quality of life, less hospitalization, and less surgery. The concept of remission has changed in the recent years. In fact the concept of clinical remission, where only the patients’ symptoms are in remission, has been replaced by the new concept of d…

medicine.medical_specialtyInflammationDiseaseClinical remissionInflammatory bowel diseaseGastroenterologyEndoscopy GastrointestinalMaintenance ChemotherapyBiological drugsCrohn DiseaseQuality of lifeRecurrenceInternal medicinemedicineHumansIntestinal MucosaWound HealingHepatologybusiness.industryMucosal healingInflammatory Bowel DiseaseRemission InductionGastroenterologymedicine.diseaseUlcerative colitisNatural historyMucosal healingColitis Ulcerativemedicine.symptombusinessDigestive and Liver Disease
researchProduct